Abstract
Cardiac troponin I (cTnI) is a key regulator of cardiac muscle contraction. Upon myocardial cell injury, cTnI is lost from the cardiac myocyte and can be detected in serum, in some cases with specific disease-induced modifications, making it an important diagnostic marker for acute myocardial injury. Presently, hospital laboratories use enzymelinked immunosorbent assays to detect cTnI, but this type of analysis lacks information about modified forms of protein (degradation or phosphorylation) that may give a more specific diagnosis from either serum or biopsies. Because cardiac and serum tissues are widely used for proteomic analysis, it is important to detect these cTnI posttranslational modifications. Therefore, we have chosen to optimize the enrichment and detection of cTnI protein by IDM Affinity Bead pull-down and surface-enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS or SELDI) analyses. By adjusting the chemical compositions of the buffers, we have retained antibody specificity and enriched for different forms of cTnI and its associated proteins.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wu, A. H. (2004) The role of cardiac troponin in the recent redefinition of acute myocardial infarction. Clin. Lab. Sci. 17, 50–52.
McDonough, J. L., Labugger, R., Pickett, W., et al. (2001) Cardiac troponin I is modified in the myocardium of bypass patients. Circulation 103, 58–64.
Labugger, R., Organ, L., Collier, C., Atar, D., and Van Eyk, J. E. (2000) Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 102, 1221–1226.
McDonough, J. L. and Van Eyk, J. E. (2004) Developing the next generation of cardiac markers: disease-induced modifications of troponin I. Prog. Cardiovasc. Disease 47, 207–216.
Gordon, A. M., Homsher, E., and Regnier, M. (2000) Regulation of contraction in striated muscle. Physiol. Rev. 80, 853–924.
Solaro, R. J. and Van Eyk, J. (1996) Altered interactions among thin filament proteins modulate cardiac function. J. Mol. Cell Cardiol. 28, 217–230.
Metzger, J. M. and Westfall, M. V. (2004) Covalent and noncovalent modification of thin filament action: The essential role of troponin in cardiac muscle regulation. Circ. Res. 94, 146–158.
Solaro, R. J. (2003) The special structure and function of troponin I in regulation of cardiac contraction and relaxation. Adv. Exp. Med. Biol. 538, 389–401.
Apple, F. S., Murakami, M. M., Pearce, L. A., and Herzog, C. A. (2002) Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 106, 2941–2945.
Apple, F. S., Wu, A. H., and Jaffe, A. S. (2002) European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am. Heart J. 144, 981–986.
Colantonio, D. A., Pickett, W., Brison, R. J., Collier, C. E., and Van Eyk, J. E. (2002) Detection of cardiac troponin I early after onset of chest pain in six patients. Clin. Chem. 48, 668–671.
Simpson, J. A., Iscoe, S., and Van Eyk, J. E. (2003) Myofilament proteomics: understanding contractile dysfunction in cardiorespiratory disease, in Proteomic and Genomic Analysis of Cardiovascular Disease (Van Eyk, J. E. and Dunn, M. J., eds.), Wiley-VCH, Germany, pp. 317–337.
Tang, N., Tornatore, P., and Weinberger, S. R. (2004) Current developments in SELDI affinity technology. Mass. Spectrom. Rev. 23, 34–44.
Katrukha, A. G., Bereznikova, A. V., Filatov, V. L., et al. (1998) Degradation of cardiac troponin I: Implication for reliable immunodetection. Clin. Chem. 44, 2433–2440.
Ardelt, P., Dorka, P., Jaquet, K., et al. (1998) Microanalysis and distribution of cardiac troponin I phospho species in heart areas. Biol. Chem. 379, 341–347.
Wu, A. H., Feng, Y. J., Moore, R., et al. (1998) Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin. Chem. 44(6 Pt 1), 1198–1208.
Foster, D. B., Noguchi, T., VanBuren, P., Murphy, A. M., and Van Eyk, J. E. (2003) C-terminal truncation of cardiac troponin I causes divergent effects on ATPase and force: implications for the pathophysiology of myocardial stunning. Circ. Res. 93(10), 917–924.
Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68(5), 850–858.
Labugger, R., Simpson, J. A., Quick, M., et al. (2003) Strategy for analysis of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry. Clin. Chem. 49(6 Pt 1), 873–879.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Bovenkamp, D.E., Stanley, B.A., Van Eyk, J.E. (2007). Optimization of Cardiac Troponin I Pull-Down by Idm Affinity Beads and SELDI-TOF. In: Vivanco, F. (eds) Cardiovascular Proteomics. Methods in Molecular Biology™, vol 357. Humana Press. https://doi.org/10.1385/1-59745-214-9:91
Download citation
DOI: https://doi.org/10.1385/1-59745-214-9:91
Publisher Name: Humana Press
Print ISBN: 978-1-58829-535-4
Online ISBN: 978-1-59745-214-4
eBook Packages: Springer Protocols